$6.77
-0.26-3.70%
At close: May 13, 5:00 PM EST
$7.03
0.263.84%
After Hours: May 12, 4:00 PM EST
Fennec Pharmaceuticals Inc Stock Guidance
FENCNASDAQ
Earnings: Q1 2026 earnings tomorrow on Thu May 14th before the market open
Fennec Pharmaceuticals (FENC) last issued guidance on February 29, 2024 for fiscal year 2023. The company guided revenue in the range of $20.70M - $21.20M for the period.
Compared to prior guidance, Fennec Pharmaceuticals raised its revenue forecast from a prior range of $9.20M - $9.70M.
Fennec Pharmaceuticals has issued 2 guidance updates between February 29, 2024 and February 29, 2024. During this period, the company raised its outlook 1 time, reflecting management's growing confidence in business performance.
Latest Guidance Date
Feb 29, 2024
Guidance Period
Full Year 2023
Revenue Guidance Range
$20.70M - $21.20M
Fennec Pharmaceuticals Guidance History
Review all historical guidance issued by Fennec Pharmaceuticals, including EPS and revenue forecasts across quarterly and annual periods.
Loading calendar...
FAQ
What is the most recent guidance for Fennec Pharmaceuticals (FENC)?
The most recent guidance for Fennec Pharmaceuticals (FENC) was reported on February 29, 2024 for the fiscal year 2023. Fennec Pharmaceuticals forecasted revenue between $20.70M and $21.20M for the period.
What revenue range did Fennec Pharmaceuticals (FENC) guide for?
Fennec Pharmaceuticals (FENC) guided revenue in the range of $20.70M to $21.20M for the fiscal year 2023.
Did Fennec Pharmaceuticals (FENC) raise or lower guidance?
Fennec Pharmaceuticals (FENC) raised its revenue guidance from a prior range of $9.20M - $9.70M to $20.70M - $21.20M for the fiscal year 2023.
When did Fennec Pharmaceuticals (FENC) last issue guidance?
Fennec Pharmaceuticals (FENC) last issued guidance on February 29, 2024 for the fiscal year 2023.
